DBV Technologies submitted a Biologics License Application (BLA) to the U.S. FDA for its VIASKIN Peanut Patch aimed at children aged 4-7 years, requesting Priority Review. The company is preparing for a potential US launch if approved, with cash reserves to fund operations into late 2027. They are also progressing on a BLA for toddlers aged 1-3 years and working on manufacturing remediation following an FDA Warning Letter. The FDA's decision on the BLA completeness and Priority Review status is expected in Q4 2026, with ongoing regulatory discussions for the toddler program.
DBV Technologies' recent business update comes as 103 of 150 priced Health-sector US stocks on Pluang rose today. For readers following this sector, here is Pluang's market snapshot as of Oct 29, 2026 03:21 WIB: Boston Scientific Corporation (BSX) traded at USD 42.25 with a 1-day change of -6.24% and Pluang order activity showing 86% Sell / 14% Buy, Inovio Pharmaceuticals Inc (INO) rose 6.22% to USD 0.95 with 65% Sell / 35% Buy activity, and Recursion Pharmaceuticals Inc (RXRX) increased 6.17% to USD 4.30 with 84% Sell / 16% Buy activity.
Fort Technology received a notification from Nasdaq on October 13, 2026, stating it failed to meet the minimum bid price requirement of $1.00 per share over the past 30 days. The company has 180 days, until April 12, 2027, to restore its share price ...
The global mobile battery market, valued at $24.9 billion in 2025, is projected to grow to $45.95 billion by 2035, driven by rising smartphone adoption, 5G rollout, and demand for longer-lasting, fast-charging batteries. Lithium-ion batteries dominat...
SpaceX reported a strong Q3 with revenue up 161% year-over-year to $14.6 billion and a net profit of $4.4 billion, reversing last year's loss. Starlink, its satellite internet service, grew revenue by nearly 70% to $5.2 billion and added 1.6 million ...
SPIE, a leading European multi-technical services provider, has signed an agreement to acquire a 76% stake in SAR ANLAGENBAU GmbH, a major electrical engineering and automation firm based in Austria and Germany. This acquisition will enhance SPIE's p...
SPIE, a European leader in energy and communication services, has agreed to acquire a 76% stake in SAR ANLAGENBAU GmbH, a key electrical engineering and automation firm in Austria and Germany. This acquisition will broaden SPIE's service portfolio in...
